Here are some of our amazing Strathclyde Women in Science who are all working towards different goals and achievements across the sector.
"I really like the application of stats and being able to study finance alongside that as well. I hope to be an actuary and I think my course will really stand me in good stead for that."
"I’m currently working in software quality assurance, I’ve got all these choices now, I can develop my skills in quality assurance or I can move into more of a software development role. It’s totally changed my life, it’s been really awesome!"
“On International Day of Women and Girls in Science, I acknowledge all women in science who improve healthcare, develop innovative medicines and ultimately save patients' lives. My PhD in immunology inspired me to join the pharmaceutical industry and gain experience in clinical research which then led me to build my own multi award winning entrepreneurial global company Clintec which now is part of IQVIA - one of the World's Most Admired companies (Fortune 500). I encourage all women to be confident and reach for the stars!"
Dr Rabinder Buttar
Global Entrepreneur, Former Founder, President & CEO Clintec International Ltd, an IQVIA companyMore about Dr Rabinder's journey
"The thing that I enjoyed most about studying here was being in the labs, getting to work with state of the art kit and just doing loads of science!"
"Before Strathclyde I was in Nigeria, I had just started a lecturing job. For a job like lecturing you need to grow, I could do it in Nigeria but I wanted to come and see what’s happening out here."
I have been very lucky to have had the opportunity to work in clinical trials for over 20 years. To play a small part in the drug development process; to help improve, change and save lives is a very great privilege.
Senior Director at a drug development company
"We've developed some new seek-and-destroy nanomedicines...and we've demonstrated that intravenous administration of this nanomedicine led to the complete disappearance of 70% of one type of [prostate cancer] tumour, and 50% of another type of [prostate cancer] tumour."
"Cancer was the course I always wanted to do. It includes care-targeted therapies and advanced biomedical research labs and quite a few new subjects which are included are drug discovery and targeted therapies."
Dr Zahra Rattray
Chancellor's Fellow & Lecturer
A career in Pharmacy has given me so many opportunities to work in the clinic helping patients, develop new medicines in industry, and now inspire the next-generation of future pharmacists.
Dr Kate Pyper
The joy of statistics is that it can be used in any field that you might be interested in, so it gives me a lot of flexibility in what I want to research - I’ve done work in public health, biomedical science, and academic publications!
I find working in science very rewarding as it is such a versatile field that is constantly advancing and it is exciting to be a part of that through teaching and research.
Dr Nur Muhamad Naim
My research interests are advanced fuzzy systems and deep learning; I love to challenge myself to simplify the complexness of the algorithms. Teaching these subjects is also my favourite. I hope my small contribution will help future generations to have a better quality of life. As a mom of two small kids, I wish the same for them.
Dr Louise Kelly
Today, the importance of Maths and Science is even more clear as we tackle issues such as Climate Change and Pandemic Recovery. It certainly is an exciting area to be working in.
Dr Susan Chalmers
Science needs women, and all diverse groups, to maintain a healthy balance of perspectives and focus – both inside science and in the wider community.
"At Strathclyde, the course has been everything I hoped it would be. It’s fast-paced and it’s innovative. At times it’s forced me to delve into my creative energy. You’re going into unknown areas. One of the first things I did on the course was to create a prototype app for people with rheumatoid arthritis in their hands."
"The eSMART study is a European randomised controlled trial in five countries across Europe of our mobile phone-based remote patient monitoring system to support patients with cancer during their chemotherapy treatment."